Bcli investors have opportunity to lead brainstorm cell therapeutics inc. securities fraud lawsuit

Los angeles , dec. 1, 2023 /prnewswire/ --  glancy prongay & murray llp ("gpm") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against brainstorm cell therapeutics inc. ("brainstorm cell" or the "company") (nasdaq: bcli). class period: august 15, 2022 – september 27, 2023 lead plaintiff deadline: january 2, 2024 if you wish to serve as lead plaintiff of the brainstorm lawsuit, you can submit your contact information at www.glancylaw.com/cases/brainstorm-cell-therapeutics-inc/.
BCLI Ratings Summary
BCLI Quant Ranking